D.A. Davidson & CO. Has $6.90 Million Stake in Intuitive Surgical, Inc. $ISRG

D.A. Davidson & CO. lifted its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 11.2% in the third quarter, HoldingsChannel.com reports. The firm owned 15,419 shares of the medical equipment provider’s stock after purchasing an additional 1,556 shares during the quarter. D.A. Davidson & CO.’s holdings in Intuitive Surgical were worth $6,896,000 at the end of the most recent reporting period.

Several other large investors have also recently bought and sold shares of ISRG. CWA Asset Management Group LLC boosted its position in Intuitive Surgical by 16.0% in the 3rd quarter. CWA Asset Management Group LLC now owns 5,189 shares of the medical equipment provider’s stock valued at $2,321,000 after buying an additional 717 shares during the last quarter. Blue Sky Capital Consultants Group Inc. lifted its stake in shares of Intuitive Surgical by 13.4% during the third quarter. Blue Sky Capital Consultants Group Inc. now owns 8,748 shares of the medical equipment provider’s stock valued at $3,912,000 after acquiring an additional 1,035 shares during the period. Crown Wealth Group LLC boosted its stake in shares of Intuitive Surgical by 14.4% in the 3rd quarter. Crown Wealth Group LLC now owns 486 shares of the medical equipment provider’s stock valued at $217,000 after purchasing an additional 61 shares during the last quarter. Stanley Laman Group Ltd. grew its holdings in Intuitive Surgical by 2,091.5% during the 3rd quarter. Stanley Laman Group Ltd. now owns 13,456 shares of the medical equipment provider’s stock worth $6,018,000 after acquiring an additional 12,842 shares during the period. Finally, Earned Wealth Advisors LLC boosted its position in shares of Intuitive Surgical by 6.3% in the 3rd quarter. Earned Wealth Advisors LLC now owns 576 shares of the medical equipment provider’s stock worth $258,000 after purchasing an additional 34 shares during the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

Intuitive Surgical Stock Performance

Shares of ISRG opened at $592.85 on Wednesday. The stock has a 50 day simple moving average of $562.72 and a 200 day simple moving average of $509.94. Intuitive Surgical, Inc. has a 52-week low of $425.00 and a 52-week high of $616.00. The firm has a market capitalization of $212.52 billion, a PE ratio of 78.42, a P/E/G ratio of 4.61 and a beta of 1.67.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings results on Tuesday, October 21st. The medical equipment provider reported $2.40 earnings per share for the quarter, beating the consensus estimate of $1.99 by $0.41. Intuitive Surgical had a net margin of 28.58% and a return on equity of 15.08%. The company had revenue of $2.51 billion during the quarter, compared to analysts’ expectations of $2.41 billion. During the same quarter in the prior year, the company earned $1.84 earnings per share. The business’s quarterly revenue was up 22.9% compared to the same quarter last year. Equities research analysts predict that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Insider Activity

In related news, CEO David J. Rosa sold 24,500 shares of the stock in a transaction dated Friday, October 24th. The stock was sold at an average price of $547.55, for a total transaction of $13,414,975.00. Following the completion of the transaction, the chief executive officer directly owned 234,256 shares in the company, valued at approximately $128,266,872.80. This trade represents a 9.47% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, EVP Henry L. Charlton sold 13,731 shares of Intuitive Surgical stock in a transaction that occurred on Wednesday, November 12th. The shares were sold at an average price of $580.00, for a total value of $7,963,980.00. Following the completion of the sale, the executive vice president directly owned 3,056 shares in the company, valued at approximately $1,772,480. This represents a 81.80% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last 90 days, insiders have sold 114,007 shares of company stock worth $63,533,844. 0.70% of the stock is currently owned by insiders.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently commented on the company. Mizuho set a $575.00 price objective on Intuitive Surgical in a report on Wednesday, October 22nd. Leerink Partners upped their price target on Intuitive Surgical from $593.00 to $600.00 and gave the company an “outperform” rating in a research note on Wednesday, October 22nd. Robert W. Baird set a $655.00 price target on shares of Intuitive Surgical in a research report on Wednesday, October 22nd. Raymond James Financial set a $603.00 price objective on shares of Intuitive Surgical and gave the company an “outperform” rating in a report on Wednesday, October 22nd. Finally, Royal Bank Of Canada increased their target price on shares of Intuitive Surgical from $625.00 to $650.00 and gave the stock an “outperform” rating in a report on Wednesday, December 17th. Two analysts have rated the stock with a Strong Buy rating, sixteen have given a Buy rating, eight have issued a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $612.75.

About Intuitive Surgical

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.